Hunan Warrant Pharmaceutical Co.,Ltd (SHA:688799)

SHA:688799 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	288.51	203.78	177.74	379.65	191.29	353.39
Short-Term Investments	-	50	296.78	349.66	181.66	-
Trading Asset Securities	-	10	183	15	325	400
Cash & Short-Term Investments	288.51	263.78	657.52	744.31	697.95	753.39
Cash Growth	-49.66%	-59.88%	-11.66%	6.64%	-7.36%	853.42%
Accounts Receivable	265.7	279.1	226.19	183.54	180.54	129.2
Other Receivables	7.45	3.21	16.5	2.14	2.19	1.49
Receivables	273.15	282.31	242.69	185.68	182.73	130.68
Inventory	387.74	392.46	412.43	362.67	339.26	300.53
Prepaid Expenses	-	3.13	2.48	1.11	1.83	2.49
Other Current Assets	180.24	234.54	118.15	55.98	26.57	18.89
Total Current Assets	1,130	1,176	1,433	1,350	1,248	1,206
Property, Plant & Equipment	1,225	1,003	687	596.78	563.76	472.98
Long-Term Investments	730.91	542.19	43.49	47.15	36.05	34.11
Goodwill	-	-	32.38	32.38	32.38	-
Other Intangible Assets	158.47	168.59	186.09	76.62	81.06	57.56
Long-Term Deferred Tax Assets	34.5	40.45	39.81	18.73	14.2	12.29
Long-Term Deferred Charges	54.96	10.99	10.44	5.32	3.26	0.23
Other Long-Term Assets	105.39	112.52	27.14	50.21	29.92	14.38
Total Assets	3,439	3,054	2,460	2,177	2,009	1,798

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	151.23	181.53	139.92	89.5	71.13	80.9
Accrued Expenses	14.52	37.06	24.51	26.04	20.61	72.81
Short-Term Debt	-	-	3.77	-	-	-
Current Portion of Long-Term Debt	1	0.37	0.05	0.01	-	-
Current Income Taxes Payable	1.28	4.38	13.32	9.97	1.29	0.94
Current Unearned Revenue	66.75	72.48	88.99	80.13	82.41	62.75
Other Current Liabilities	204.52	114.88	148.46	130.73	119.4	42.19
Total Current Liabilities	439.3	410.7	419.02	336.38	294.83	259.59
Long-Term Debt	772.04	497.6	113.93	17.11	-	-
Long-Term Unearned Revenue	102.68	102.65	98.8	49.94	53.19	56.92
Long-Term Deferred Tax Liabilities	-	-	0.02	-	2.33	0.01
Other Long-Term Liabilities	-	-	5.28	5.28	-	1.55
Total Liabilities	1,315	1,011	637.06	408.7	350.35	318.07

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	133.64	131.32	93.8	93.8	93.8	93.8
Additional Paid-In Capital	908.11	870.1	850.34	850.34	850.34	850.34
Retained Earnings	1,082	1,041	859.27	779.37	652.47	535.33
Total Common Equity	2,124	2,043	1,803	1,724	1,597	1,479
Minority Interest	-	-	19.17	44.73	62.01	-
Shareholders' Equity	2,124	2,043	1,823	1,768	1,659	1,479
Total Liabilities & Equity	3,439	3,054	2,460	2,177	2,009	1,798

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	774.12	497.98	117.75	17.12	-	-
Net Cash (Debt)	-485.61	-234.2	539.77	727.19	697.95	753.39
Net Cash Growth	-	-	-25.77%	4.19%	-7.36%	853.42%
Net Cash Per Share	-3.61	-1.74	4.11	5.53	5.32	6.73
Filing Date Shares Outstanding	129.29	131.32	131.32	131.32	131.32	131.32
Total Common Shares Outstanding	129.29	131.32	131.32	131.32	131.32	131.32
Working Capital	690.34	765.52	1,014	1,013	953.5	946.38
Book Value Per Share	16.43	15.56	13.73	13.12	12.16	11.27
Tangible Book Value	1,965	1,874	1,585	1,615	1,483	1,422
Tangible Book Value Per Share	15.20	14.27	12.07	12.29	11.29	10.83
Buildings	-	467.65	316.97	325.35	313.1	304.86
Machinery	-	581.56	539.11	491.33	372.49	274.63
Construction In Progress	-	323.73	143.06	27.62	70.5	43.05

Data Source: S&P Global Market Intelligence Last updated: Aug 24, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 10, 2026

Data Sources Report a data error